Human Papillomavirus Type 6 and 11 Genetic Variants Found in 71 Oral and Anogenital Epithelial Samples from Australia

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Danielewski, Jennifer A ^a,b   Garland, Suzanne M ^a,b,c   McCloskey, Jenny ^d,e   Hillman, Richard J ^f   Tabrizi, Sepehr N ^a,b,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CANCER; ARTICLE; AUSTRALIA; BINDING SITE; CANCER CELL; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; E6 GENE; E7 GENE; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GEOGRAPHY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INDEL MUTATION; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PAPILLOMATOSIS; PROMOTER REGION; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA IN SITU; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; AMINO ACID SEQUENCE; ANUS TUMOR; DNA SEQUENCE; GENETICS; MOLECULAR GENETICS; MOUTH MUCOSA; PAPILLOMAVIRUS INFECTIONS; REGULATOR GENE; RESPIRATORY TRACT INFECTION; VIROLOGY;

AMINO ACID SEQUENCE; ANUS NEOPLASMS; AUSTRALIA; BASE SEQUENCE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; LOCUS CONTROL REGION; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; PAPILLOMAVIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SEQUENCE ANALYSIS, DNA;

EID: 84877858522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063892     Document Type: Article

References (66)

1. Doorbar J, Griffin H, (2007) Intrabody strategies for the treatment of human papillomavirus-associated disease. Expert Opin Biol Ther 7: 677-689.
2. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
3. Garland SM, Steben M, Sings HL, James M, Lu S, et al. (2009) Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 199: 805-814.
4. Komlos KF, Kocjan BJ, Kosorok P, Luzar B, Meglic L, et al. (2012) Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol 84: 1233-1241.
5. Oriel JD, (1971) Natural history of genital warts. Br J Vener Dis 47: 1-13.
6. Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, et al. (2005) Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191: 731-738.
7. Fairley CK, Donovan B, (2010) What can surveillance of genital warts tell us? Sex Health 7: 325-327.
8. Scarbrough Lefebvre CD, Van Kriekinge G, Goncalves MA, de Sanjose S, (2011) Appraisal of the burden of genital warts from a healthcare and individual patient perspective. Public Health 125: 464-475.
9. Pirotta M, Ung L, Stein A, Conway EL, Mast TC, et al. (2009) The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect 85: 508-513.
10. McCloskey JC, Metcalf C, French MA, Flexman JP, Burke V, et al. (2007) The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS 18: 538-542.
11. Hartwig S, Syrjanen S, Dominiak-Felden G, Brotons M, Castellsague X, (2012) Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 12: 30.
12. Lehn H, Ernst TM, Sauer G, (1984) Transcription of episomal papillomavirus DNA in human condylomata acuminata and Buschke-Lowenstein tumours. J Gen Virol 65 (Pt 11): 2003-2010.
13. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, et al. (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365: 1576-1585.
14. Insinga RP, Liaw KL, Johnson LG, Madeleine MM, (2008) A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 17: 1611-1622.
15. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM, (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 128: 927-935.
16. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L, (2004) Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114: 1-23.
17. Syrjanen S, (2010) Current concepts on human papillomavirus infections in children. APMIS 118: 494-509.
18. Derkay CS, Wiatrak B, (2008) Recurrent respiratory papillomatosis: a review. Laryngoscope 118: 1236-1247.
19. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK, (1998) Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 108: 735-740.
20. Jin F, Stein AN, Conway EL, Regan DG, Law M, et al. (2011) Trends in anal cancer in Australia, 1982-2005. Vaccine 29: 2322-2327.
21. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR, (2004) Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101: 281-288.
22. Dona MG, Palamara G, Di Carlo A, Latini A, Vocaturo A,et al. (2012) Prevalence, genotype diversity and determinants of anal HPV infection in HIV-uninfected men having sex with men. J Clin Virol.
23. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A,et al. (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol.
24. Wentzensen N (2012) Screening for anal cancer: endpoints needed. Lancet Oncol.
25. Frisch M, Glimelius B, Wohlfahrt J, Adami HO, Melbye M, (1999) Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst 91: 708-715.
26. Hoots BE, Palefsky JM, Pimenta JM, Smith JS, (2009) Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 124: 2375-2383.
27. Komlos KF, Kocjan BJ, Kosorok P, Rus T, Toplak J, et al. (2011) Distribution of HPV genotypes in Slovenian patients with anal carcinoma: preliminary results. Acta Dermatovenerol Alp Panonica Adriat 20: 141-143.
28. Stevens MP, Tabrizi SN, Quinn MA, Garland SM, (2006) Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer 16: 1017-1024.
29. Al-Awadhi R, Chehadeh W, Kapila K, (2011) Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. J Med Virol 83: 453-460.
30. Panotopoulou E, Tserkezoglou A, Kouvousi M, Tsiaousi I, Chatzieleftheriou G, et al. (2007) Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women. J Med Virol 79: 1898-1905.
31. Stevens MP, Garland SM, Tan JH, Quinn MA, Petersen RW, et al. (2009) HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol 81: 1283-1291.
32. Nevins JR, (2001) The Rb/E2F pathway and cancer. Hum Mol Genet 10: 699-703.
33. Rosty C, Sheffer M, Tsafrir D, Stransky N, Tsafrir I, et al. (2005) Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene 24: 7094-7104.
34. Scheffner M, Munger K, Byrne JC, Howley PM, (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A 88: 5523-5527.
35. Gall T, Kis A, Feher E, Gergely L, Szarka K, (2011) Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates. Antiviral Res 92: 356-358.
36. Grassmann K, Wilczynski SP, Cook N, Rapp B, Iftner T, (1996) HPV6 variants from malignant tumors with sequence alterations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid exchanges in the E6 and E7 proteins. Virology 223: 185-197.
37. Kocjan BJ, Poljak M, Cimerman M, Gale N, Potocnik M, et al. (2009) Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6). Virology 391: 274-283.
38. Kovelman R, Bilter GK, Roman A, Brown DR, Barbosa MS, (1999) Human papillomavirus type 6: classification of clinical isolates and functional analysis of E2 proteins. J Gen Virol 80 (Pt 9): 2445-2451.
39. Krige D, Mills HR, Berrie EL, Doherty NC, Jones DK, et al. (1997) Sequence variation in the early genes E1E4, E6 and E7 of human papilloma virus type 6. Virus Res 49: 187-191.
40. Chansaenroj J, Theamboonlers A, Junyangdikul P, Supiyaphan P, Poovorawan Y, (2012) Whole genome analysis of human papillomavirus genotype 11 from cervix, larynx and lung. Asian Pac J Cancer Prev 13: 2619-2623.
41. Combrinck CE, Seedat RY, Randall C, Roodt Y, Burt FJ, (2012) Novel HPV-6 variants of human papillomavirus causing recurrent respiratory papillomatosis in southern Africa. Epidemiol Infect 140: 1095-1101.
42. Kocjan BJ, Jelen MM, Maver PJ, Seme K, Poljak M, (2011) Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV 6): a comparative analysis of 21 full-length genome sequences. Infect Genet Evol 11: 1805-1810.
43. Maver PJ, Kocjan BJ, Seme K, Potocnik M, Gale N, et al. (2011) Prevaccination genomic diversity of human papillomavirus genotype 11: a study on 63 clinical isolates and 10 full-length genome sequences. J Med Virol 83: 461-470.
44. Gabbott M, Cossart YE, Kan A, Konopka M, Chan R, et al. (1997) Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 35: 3098-3103.
45. Heinzel PA, Chan SY, Ho L, O'Connor M, Balaram P, et al. (1995) Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 33: 1746-1754.
46. O'Connor M, Chan SY, Bernard HU (1995) Transcription factor binding sites in the long control regions of genital HPVs. In G Meyers, H U Bernard, H Delius, C Baker, J Icenogle, A Halpern, and C Wheeler (ed), Human papillomaviruses, 1995 compendium, part III-A. ed: Los Alamos National Laboratory, Los Alamos, N.Mex. 21-40.
47. Burk RD, Chen Z, Harari A, Smith BC, Kocjan BJ, et al. (2011) Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Panonica Adriat 20: 113-123.
48. Somers GR, Tabrizi SN, Borg AJ, Garland SM, Chow CW, (1997) Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study. Pediatr Pathol Lab Med 17: 53-64.
49. Moore EE, Danielewski JA, Garland SM, Tan J, Quinn MA, et al. (2011) Clearance of human papillomavirus in women treated for cervical dysplasia. Obstet Gynecol 117: 101-108.
50. Stevens MP, Rudland E, Garland SM, Tabrizi SN, (2006) Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol 44: 2428-2433.
51. Tan SE, Garland SM, Rumbold AR, Tabrizi SN, (2010) Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays. J Clin Microbiol 48: 1458-1460.
52. Tan SE, Garland SM, Rumbold AR, Tabrizi SN, (2011) Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and/or neoplasia tissue biopsy specimens. J Clin Microbiol 49: 3980-3982.
53. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, editors. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press. 365-386.
54. Gouy M, Guindon S, Gascuel O, (2010) SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 27: 221-224.
55. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
56. Wu X, Zhang C, Feng S, Liu C, Li Y, et al. (2009) Detection of HPV types and neutralizing antibodies in Gansu province, China. J Med Virol 81: 693-702.
57. Kocjan BJ, Gale N, Hocevar Boltezar I, Seme K, Fujs Komlos K, et al. (2013) Identical Human Papillomavirus (HPV) Genomic Variants Persist in Recurrent Respiratory Papillomatosis for up to 22 Years. J Infect Dis 207: 583-587.
58. Ure AE, Forslund O, (2012) Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas. J Virol 86: 13790-13794.
59. Reidy PM, Dedo HH, Rabah R, Field JB, Mathog RH, et al. (2004) Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 114: 1906-1909.
60. Rabah R, Lancaster WD, Thomas R, Gregoire L, (2001) Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 4: 68-72.
61. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, et al. (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377: 2085-2092.
62. Gertig DM, Brotherton JM, Saville M, (2011) Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 8: 171-178.
63. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, et al. (2009) Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect 85: 499-502.
64. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, et al. (2011) The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87: 544-547.
65. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG,et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 11: 39-44.
66. Kimura M, (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16: 111-120.